ロード中...
4CPS-041 Drug survival of biologic therapies for the treatment of psoriasis
BACKGROUND: Biologic drug survival is defined as the time from initiation of biologic therapy to discontinuation, which can be due to ineffectiveness, adverse events or other reasons. It is an important measurement of overall treatment success in psoriasis and a priority in clinical practice. Clinic...
保存先:
| 出版年: | Eur J Hosp Pharm |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMJ Group
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7535264/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.132 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|